Latest Blog Posts

FDA recalls Viapro due to potential drug injuries

by fpw | July 31st, 2008

July 31, 2008 The FDA has alerted that EG Labs issued a recall of Viapro 375 mg supplement products due to a dangerous ingredient that could cause drug injuries. Drug injuries could occur because a certain lot of Viapro was tested and proven to contain undeclared ingredient thio-methisosildenafil, which is an analog of Sildenafil, the

Read More

FDA seizes Xiadafil VIP tablets due to potential drug injuries

by fpw | July 29th, 2008

July 29, 2008 The FDA is seizing Xiadafil VIP tablets due to the potential for drug injuries after the company refused to recall the drug. Xiadafil VIP tablets, which were given away at trade shows and distributed by SEI Pharmaceuticals, Inc., contain an ingredient similar to Sildenafil, which is the active ingredient in Viagra for

Read More

Sodium Polystyrene Sulfate Suspension recalled: risk of drug injury

by fpw | July 24th, 2008

July 24, 2008 The FDA reported that Roxane Laboratories, Inc. has recalled Sodium Polystyrene Sulfate Suspension, a product used for the treatment of hyperkalemia due to potential for drug injury. The affected lots of Sodium Polystyrene Sulfate Suspension have been found to have a strain of yeast in them which could cause drug injuries to

Read More

Drug company warns against drug injuries

by fpw | July 22nd, 2008

July 22, 2008 Reuters reported that Genetech has warned doctors about a drug injury seen in patients who are taking Avastin along with Pfizer’s Sutent during a clinical trial. Avastin, Genetech’s block-buster cancer drug, used in combination with Pfizer’s Sutent can cause drug injuries such as microangiopathic hemolytic anemia. Avastin is approved to treat colon,

Read More